Phentolamine administration increases blood S100B protein levels in pediatric open-heart surgery patients.
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology*; D002315:Cardiopulmonary Bypass; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D005260:Female; D006801:Humans; D007223:Infant; D017078:Laser-Doppler Flowmetry; D008297:Male; D009414:Nerve Growth Factors / Q000097:blood*; D010646:Phentolamine / Q000009:adverse effects / Q000494:pharmacology*; D011673:Pulsatile Flow / Q000187:drug effects; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins / Q000097:blood*; D014655:Vascular Resistance / Q000187:drug effects; D015300:Ventilator Weaning
D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D009414:Nerve Growth Factors; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins; C579160:S100B protein, human; D010646:Phentolamine